OncoMed Pharmaceuticals, Inc. is a clinical development-stage biotechnology company. It engages in the provision of discovering and developing protein therapeutics targeting cancer stem cells. The company was founded by Drs. Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA.
